The abstract submission deadline is now CLOSED.
Abstracts should contain the following four components:
- Background: a concise statement of the issue under investigation or a hypothesis;
- Materials & Methods: the experimental methods used (including the statistical analyses employed);
- Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note: that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included.
The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. For abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.
Authors can submit their abstracts electronically using the button on the right "Abstract Submission". You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract.
To ensure your abstract retains any special characters or formatting, the abstract must be submitted in Microsoft Word format.
Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract.
Topics for abstract submission
Selection of the most appropriate topic is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.
Abstracts will be accepted either for oral or poster presentation.
Abstracts can be submitted under the following categories:
- Working towards Eradication of Viral Hepatitis
- Global Status of Viral Hepatitis Prevalence and Treatment
- Immunological Approaches and Vaccines
- Clinical Strategies to Eradicate HBV
- Preclinical and Clinical Advances in Viral Hepatitis Therapeutics and outcomes.
- Obstacles to cures including resistance
- Approaches to Treat NASH
- Therapies for HCC
- Infections or Co-infections With HIV, HBV, and Other Viruses
Notification of abstract acceptance and presentation format
It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Notifications of acceptance and format of presentation (oral or poster presentation) will be announced in the first week of November. Please notify the Conference Secretariat if you have not received notification. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.
Accepted abstracts will be published in the Abstract Book, which will be distributed during the conference. All abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typographic or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.
Oral Abstract Presenter Guidelines
You can download the directions for oral abstract presentations here: Oral Abstract Guidelines